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Abstract 
 
Background: The aim of this study was to measure the parameters of oxidative stress in the 
blood of patients with post-traumatic stress disorder (PTSD).  
Methods: The study included 80 male war veterans who participated actively in the 
Homeland war in Croatia. Volunteers were divided into two groups: 50 veterans diagnosed 
with post-traumatic stress disorder (PTSD) and 30 without diagnosis. The self-assessment 
Hospital Anxiety and Depression Scale (HADS) and the Beck Depression Inventory (BDI-II) 
were used to detect the severity of depression and anxiety in the PTSD patients. Catalytic 
concentrations of superoxide dismutase (eSOD) and glutathione peroxidase (eGPx) in 
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erythrocytes and the level of malondialdehyde (sMDA) in serum were measured 
spectrophotometricaly. 
Results: Although the catalytic concentrations of eSOD and eGPx were within the reference 
range for both groups, the values obtained for the PTSD group were significantly lower (P < 
0.001). For sMDA levels no statistically significant differences between the groups were 
found.   
Conclusions: Lower catalytic concentrations of eSOD and eGPx in patients with PTSD may 
indicate a weaker response to oxidative stress due to impaired enzyme activity and/or 
decreased synthesis. Conversely, no significant changes in sMDA concentrations suggest a 
compensated balance and adaptive response to (oxidative) stress.  
 
Introduction 
 
Free radicals, atoms, molecules or ions with an unpaired number of electrons are 
physiological products of metabolism which directly participate in the protection against 
infection, or act as coordinators of inflammatory response.1 In a healthy organism the 
production and various interactions of free radicals are tightly controlled by enzymatic 
defense mechanisms such as the superoxide dismutase (SOD), glutathione peroxidase (GPx) 
and catalase (CAT), or via the action of non-enzymatic antioxidants such as ascorbic acid, 
vitamin E and glutathione.2 However, excessive production of free radicals and/or impaired 
protection mechanisms lead to oxidative stress and result in radical-induced damage of lipids, 
proteins and DNA.3 Tissue damage caused by oxidative stress includes a diversity of 
biological phenomena such as aging, carcinogenesis, atherosclerosis, and neurodegeneration.4 
The severity of oxidative stress can be measured via the level of reactive oxygen/nitrogen 
species (ROS/RNS) or the level of antioxidants. Furthermore, biomolecules derived through 
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the action of free radicals can be used as markers of oxidative stress: damaged DNA/RNA (i. 
e. 8-hydroxy(deo)guanosine), the oxidation/nitration of proteins (i. e. protein carbonyl 
content), and the products of lipid peroxidation (i. e. 4-hydroxy-2-nonenal, HNE; 
malondialdehyde, MDA).  
Lipid peroxidation, defined as the oxidative deterioration of lipids containing any number of 
carbon-carbon double bonds, is considered to participate significantly in the creation of 
oxidative stress, since polyunsaturated fatty acids (PUFAs) frequently serve as a target for 
free radicals resulting in their multiplication through a cascade of reactions.1 The primary 
products of lipid peroxidation which include conjugated dienes and hydroperoxides, are 
relatively unstable and decompose into secondary products such as alcohols, aldehydes, and 
ketones. Although numerous state of the art methods have been developed, the level of overall 
lipid peroxidation is still most frequently assessed as the concentration of serum 
malondialdehyde (sMDA) which is determined by a reaction with thiobarbituric acid (TBARS 
Assay).  
Lipids comprise about 60% of the brain's dry weight with a high ratio of PUFAs, and the 
brain utilizes more than 20 % of total O2 consumed by the body, which is why the brain is 
highly susceptible to lipid peroxidation that might result in serious damages and loss of 
function.5-7 Oxidative stress may alter neurotransmission patterns, neuronal function and brain 
activity in general, and can also disrupt the membrane integrity.8,9 Both the importance of 
fatty acid composition in brain cell membranes and the involvement of PUFAs in the 
development of various psychiatric disorders have been intensively studied.10-12 A significant 
number of these results point to a relationship between the lack of essential PUFAs, 
particularly eicosapentaenoic (EPA, C20:5n-3) and docosahexaenoic (DHA, C22:6n-3), and a 
variety of psychiatric symptoms and disorders such as stress, anxiety, cognitive impairment, 
mood disorders and schizophrenia. In our previous study13 a significant negative correlation 
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between plasma EPA level and the severity of clinical symptoms in patients with post-
traumatic stress disorder (PTSD) was found.  
According to recently released DSM V criteria14, post-traumatic stress disorder (PTSD) is 
classified as a trauma- and stressor-related disorder caused by a traumatic experience such as 
exposure to actual or threatened death, serious injury or sexual violation. It is characterized by 
four major symptom clusters: reexperiencing, arousal, avoidance, and persistent negative 
alterations in cognitions and mood. The evolvement of PTSD results in impairments in the 
individual’s social interactions, work capability or everyday functioning, although it is unclear 
why certain individuals develop PTSD as a reaction to traumatic incidents while others do 
not.  
Since oxidative stress is a general phenomenon and the markers of oxidative damage in the 
central nervous system (CNS) correlate well with those in peripheral materials, the majority 
of analyses were performed on easily accessible materials such as blood, saliva, and 
cerebrospinal fluid.5A substantial number of authors found increased amounts of markers of 
oxidative stress in plasma/serum, and/or deviations in the activity of defense enzymes in 
patients suffering from psychiatric disorders.3,7,15-19 A recent review by Hovatta et al.20 
analysed available data on the relationship between oxidative stress and anxiety, depression 
and co-morbid disorders, and the possible mechanisms of impaired defense against oxidative 
stress. Stress induced alterations in the level of neurotransmitters such as excitatory amino 
acids (EAA), serotonin, and gamma-amino-butyric acid (GABA) can modulate the immune 
response and vice versa, cytokines, mediators produced by immune cells, maintain 
homeostasis by communicating with other biological systems, such as the hypothalamic-
pituitary-adrenal (HPA) axis.21,22  
Recently, Kuloglu et al.23,24  recognized a link between oxidative stress and some anxiety 
disorders (obsessive-compulsive and panic disorder), demonstrating that oxidative 
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metabolism can influence anxiety regulation. Bouayed et al.25 in their review summarized 
data which demonstrate a link between oxidative stress and anxiety, but an unambiguous 
cause-effect relationship has yet to be determined. Some of the reviewed studies suggest 
oxidative stress causes anxiety-related behaviors but none clarify the underlying, specific 
mechanisms in detail. 
The risk factors for developing PTSD appear to be related to a combination of genetic 
predisposition and environmental factors.26,27 It was first recognized among Vietnam War 
veterans but was also subsequently diagnosed in people expressing similar symptoms in 
response to various traumas, whether in war or civil life.28 During the 1990s the Homeland 
War struck Croatia. This unfortunate experience resulted in a vast number of individuals 
suffering from PTSD.  Since PTSD has some clinical symptoms similar to those found in 
depression, bipolar disorder, schizophrenia, and other psychiatric disorders, the present study 
investigates whether similar changes in oxidative/antioxidative balance could be confirmed. 
Certain lifestyle and nutritional habits, which are possible cofactors in the processes of 
oxidative stress, were also observed in the study participants.  
 
Subjects and methods 
 
Subjects 
The study included 80 male Croatian Homeland War veterans. Fifty veterans were outpatients 
from University Psychiatric Hospital Vrapče who were diagnosed with PTSD according to the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)29, and the International 
Statistical Classification of Diseases and Related Health Problems (ICD-10)30 diagnostic 
criteria. The control group included 30 participants who had also served in the Homeland 
War, but did not develop PTSD. The diagnosis evaluation was performed by experienced 
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psychiatrists in order to confirm the PTSD diagnoses according to the DSM-IV and ICD-10. 
Although an updated edition of the manual (DSM-V)14 was released in the meantime, where 
PTSD is detached from anxiety disorders and included in a new section of trauma- and 
stressor-related disorders, all our patients met the criteria for PTSD diagnosis according to 
both DSM IV and V. The self-assessment Hospital Anxiety and Depression Scale (HADS)31 
and the Beck Depression Inventory (BDI-II)32 were used to detect the severity of depression 
and anxiety in the PTSD patients. The 21 BDI-II items, as well as 14 items from the HADS, 
are each scored on a four-point scale from 0 = “no symptoms” to 3 = “extreme symptoms”. 
The sum of the first seven items from the HADS is the severity index for anxiety, and the sum 
of the last seven is the index for depression. The severity of PTSD was evaluated by a 
clinician-rated instrument, i.e. the Clinical Global Impression – Severity scale (CGI-S).33 The 
severity of the patient's PTSD is assessed by CGI-S in a 7 point range: from 1 ("normal, not at 
all ill") to 7 (“extremely ill“). All the participants were free of all medication for at least two 
weeks prior to entering the study, with the exception of veterans with PTSD who were treated 
with an antidepressant (sertraline, 50 mg/day) for at least 2 months. Ten of the PTSD patients 
were also on therapy with anxiolytics (4 - diazepam; 3 - alprazolam; 3 - lorazepam). 
Exclusion criteria were: alcohol and substance abuse or dependence, food supplementation 
(i.e. vitamins E and/or C), presence of a severe neurologic disorder, presence of an infectious 
disease, or presence of a severe physical disorder. The study protocol was approved by the 
Ethics Committees of the University Psychiatric Hospital Vrapče and the School of Medicine 
University of Zagreb, Croatia. Prior to entering the study all participants signed an informed 
consent, and afterwards completed a general health questionnaire.34 
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Blood sample collection 
Vein blood samples were collected after overnight fasting into 5 mL vacutainer tubes (Becton 
Dickinson, Franklin Lakes, NJ, USA) containing EDTA. The samples were then centrifuged 
at 3000 rpm for 10 min at 15 °C to separate the plasma from blood cells. After washing 
procedures, erythrocytes isolated from blood samples were hemolysed by the freezing and 
thawing sequence. 
 
Measurement of antioxidant enzymes activity 
Hemolysates of erythrocytes were used to measure catalytic concentrations of erythrocyte 
glutathione peroxidase (eGPx) (EC 1.11.1.9) and erythrocyte superoxide dismutase (eSOD) 
(EC 1.15.1.1), as well as hemoglobin (Hb) concentration. The eGPx activity in erythrocyte 
hemolysates was measured using a commercial RANSEL kit and eSOD activity was 
measured with RANSOD reagent (both from Randox Laboratories Ltd., Dublin, Ireland) on 
SABA 18 auto-analyzer (AMS, Rome, Italy). The eGPx activity, expressed in nanomoles of 
NADPH oxidized per minute, was measured by a coupled modification of the assay procedure 
of Paglia and Valentine.35 The assay for eSOD activity was based on the method described by 
Woolliams et al.36, using xanthine and xanthine oxidase to produce superoxide radicals which 
then react with nitroblue tetrazolium to form a red formazan dye. The inhibitory effects of 
eSOD on the initial rate of this reaction were measured, and one unit of SOD activity is that 
which causes a 50% inhibition of the rate of reduction of the substrate under the conditions of 
the assay. In hemolysates a mass concentration of hemoglobin was also measured (Herbos 
Dijagnostika, Sisak, Croatia) and eGPx and eSOD catalytic concentrations were expressed in 
terms of U/g Hb. 
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Determining serum malondialdehyde levels 
Serum MDA levels were measured using the modified thiobarbituric acid method described 
by Anguloa et al.37, and Botsoglou et al.38 Results were calculated and expressed as 
concentration of MDA (µmol/L) using the extinction coefficient of 156 000 Lmol-1cm-1.39 
 
Laboratory methods 
Serum triacylglycerols (TG), total cholesterol (T-CH) and HDL cholesterol (HDL-CH) were 
measured by enzymatic colorimetric methods (Roche Diagnostics Corporation, Indianapolis, 
IN, US). Low density lipoprotein cholesterol (LDL-CH) was calculated as described by 
Friedewald et al.40 
 
Statistical analysis 
The obtained data were evaluated with STATISTICA 10 software (StatSoft, Inc., Tulsa, 
Oklahoma, USA). The data distribution was tested with Kolmogorov-Smirnov and Shapiro 
Wilk's W test. Descriptive statistics were performed, and the results are presented as mean ± 
standard deviation (mean±SD). Results were processed by Student-t test, Mann Whitney and 
Chi-square test, and the correlation of study parameters was tested by Spearman rank order 
correlations. The observed differences were considered statistically significant at the level of 
P<0.05. 
 
Results  
Demographic data 
A total of 80 male volunteers who participated actively in the Croatian Homeland War in the 
1990s were enrolled in this study. The PTSD group included 50 outpatients with a mean age 
of 44.6 years (range 34-58 years). The socio-demographic and biochemical characteristics of 
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the PTSD patients and the control group are summarized in Table 1. The participants from the 
PTSD group and control group did not differ significantly regarding the duration of exposure 
to combat trauma, nor in the time elapsed after the war trauma terminated. The degree of 
education was significantly higher within the control group (66.67 % with higher education) 
while participants from the PTSD group had mainly a secondary school degree (81.63 %). At 
the time of their participation in the study most of the PTSD veterans were either retired or 
unemployed. 
 
Lifestyle and nutritional habits 
Data on nutritional habits included information about the body mass index (BMI) as well as 
the consumption of fish and various oils (Table 1). The mean BMI value was similar for both 
groups. Regarding the oil type, sunflower oil was preferred in both groups with significantly 
higher consumption frequencies recorded in patients with PTSD (P = 0.0203). However, the 
control group consumed significantly more olive oil compared to the PTSD group (P = 
0.0025). For fish consumption no significant differences were found between the groups. 
Analysis of laboratory data revealed no significant differences in lipid parameters between the 
two groups. 
 
Severity of depression and anxiety in PTSD participants 
The comparison between the severity of PTSD, depression and anxiety in the PTSD group is 
presented in Figure 1. The total sum of points from BDI-II is originally assembled in four 
subscores in the following order: minimal depression (0-11 points); mild depression (12-19 
points); moderate depression (20-26 points); and severe depression (≥27 points). However, 
since HADS gives three subscores: (1) no symptoms (0-7 points); (2) moderate symptoms (8-
10 points); and (3) severe symptoms (11-21 points), for the purpose of this study the first two 
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subscores from BDI-II have been summarized into one combined subscore, to ensure data 
comparability. The PTSD severity in participants, evaluated by CGI-S, ranged between the 
following four subscores: mildly ill, moderately ill, markedly ill and severely ill. For the 
purpose of this study the last two subscores (markedly ill and severely ill) have been 
summarized into one combined subscore. Statistical tests confirmed a strong positive 
correlation between the anxiety (HADS-A) and depression severity index (HADS-D) obtained 
by HADS alone (r = 0.741, P<0.05). Positive correlations were also observed between the 
results obtained by the three different scales: BDI-II vs. HADS-A (r = 0.835, P<0.05), BDI-II 
vs. HADS-D (r = 0.716, P<0.05), and between CGI-S vs. BDI-II (r = 0.53, P <0.05). 
 
Antioxidant enzymes’ activity and MDA levels in the PTSD and control group 
Data for the eSOD and eGPx catalytic concentrations and sMDA concentration of the control 
and the PTSD group are shown in Fig. 2. Values for catalytic concentrations of antioxidative 
enzymes are expressed as U/mg Hb in order to avoid possible errors resulting from 
erythrocyte washing and dilution. Mass concentrations of Hb were within reference values 
and did not differ significantly between the two groups. A significant difference was noted 
between PTSD and the control group in eSOD (t = 4.1307; P = 0.000090) and eGPx (t = 
3.53797; P = 0.000683) activities, with lower values exhibited in the PTSD group. No 
significant differences were found in sMDA levels. The data analysis was further focused on 
relations between the component traits of (anti)oxidative status and serum lipids level. A 
statistically significant correlation was only found for eSOD activity vs. serum TCH level (r = 
- 0.3322, P < 0.0500) for patients with PTSD. This relationship was not confirmed neither for 
the control group (r = 0.1384; P > 0.0500), nor for the total group (r = 0.0161; P > 0.0500). 
Other tested correlations were also not significant (all P > 0.005, data not shown). 
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Discussion 
Very few studies have been conducted on patients afflicted with a combat related PTSD, and 
to the best of our knowledge, none of them analyzed the relationship between parameters of 
oxidative stress and the severity of clinical symptoms. 
Fifty patients who met the DSM-IV criteria for PTSD but did not have any previously 
documented somatic illnesses were recruited among outpatients in the University Psychiatric 
Hospital Vrapče, Zagreb, Croatia. Traumatic experiences during the Homeland War acted as a 
trigger for PTSD development for all of them. The control group was matched with 30 
healthy volunteers who also served in the Homeland War, fortunately without serious 
consequences on their mental health. All participants were males of similar age, and the time 
spent in the war did not differ significantly between groups. Thus two homogeneous groups 
were obtained according to gender, age, stressor and duration of illness. 
The adverse effects and the intensity of the damage caused by free radicals strongly depend 
on the protective action of enzymatic (i.e. SOD, GPx, and catalase) as well as non-enzymatic 
antioxidants (i.e. vitamins A, C and E, glutathione and selenium). In our study, the catalytic 
concentrations of eSOD and eGPx were within the reference range for both groups, but 
statistically significant differences for eSOD and eGPx activity between the two groups were 
found, with lower values obtained for the PTSD group. Similar results for SOD and GPx were 
obtained by Dadheech et al.41 in blood of patients with schizophrenia, while Akyol et al.42 
reported decreased SOD with unchanged GPx catalytic concentrations. 
Superoxide dismutase and GPx are related enzymes since the latter removes hydrogen 
peroxide, produced by SOD during superoxide radical dismutation. A positive correlation 
between SOD and GPx was demonstrated when tested in all participants as a whole (r = 0.56; 
P < 0.05). This positive correlation between SOD and GPx was again confirmed when tested 
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within each study group separately (r = 0.50; P < 0.05 for PTSD group, and r = 0.43; P < 0.05 
for control group).  
These results could be explained through the data described by Zieker et al.43 who referred 
different gene expression pattern in patients with PTSD, with SOD being downregulated. In 
addition, genes for some interleukins and thioredoxin, another protein involved in 
antioxidative defense, were also downregulated. In contrast to the above-mentioned results, 
Tezcan et al.44 did not find any difference in SOD and GPx activities between patients with 
PTSD and healthy controls. In literature there are reports on lower SOD activity being related 
to aging processes and some other disorders.45,46 Attention is drawn to the negative correlation 
between eSOD activity and cholesterol level, specifically in the PTSD group. Although 
similar relationships were observed in human and animal studies with nutritional interventions 
with different types and amounts of fats,47,48 available data are ambiguous and the final 
explanation of related mechanisms is yet to be found. 
Oxidative stress is demonstrated by increased levels of plasma peroxides.49 Dadheech et al.41 
and Akyol et al.42 have found increased oxidative stress in patients with schizophrenia as 
indicated by higher MDA levels. However, in our study concentration of sMDA did not differ 
significantly between the two groups. Likewise, Tezcan et al.44 did not find any increase in 
MDA concentration in the serum of PTSD patients.  
The principal targets of lipid peroxidation are unsaturated fatty acids originating mainly from 
food. Therefore some nutritional habits of the participants were compared, i.e. oil type and 
frequency of fish consumption. Generally, no significant differences were found between the 
two groups, with the exception of oil type consumption. Although the control group 
consumed more olive oil, no correlations with serum lipid parameters, antioxidant enzyme 
activities and sMDA levels were found. Additionally, age, time spent in the war, BMI, and 
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fish consumption did not correlate significantly with parameters of oxidative stress (P>0.05 
for all correlations) (data not shown).  
Since anxiety and depression are the most common comorbid symptoms in PTSD, self-report 
questionnaires were given to the affected participants. More than 50 % of them reported 
severe and about 20 % reported moderate symptoms of depression in BDI-II as well as in 
HADS. Separate scores for depression and anxiety from HADS revealed anxiety symptoms to 
be more pronounced. Most of the participants with PTSD were moderately ill when evaluated 
by the clinician-rated scale. Observed discrepancies between clinician-rated and self-
administered severity of illness were reported in a number of studies.50  
It is worth noting that the education level was significantly higher in the control compared to 
the PTSD group, and higher education may indicate better cognitive abilities. Similarly, 
Horner and Hamner (2002)51 in their review of performance on standard neuropsychological 
tests among individuals with PTSD suggested that certain individuals who are at risk for 
developing PTSD are also characterized by subtle cognitive deficits. Whether or not, and 
how, the level of education and cognitive abilities can be related to the likelihood that certain 
trauma will result in PTSD development, still remains to be investigated. Furthermore, 
because of their disease, the majority of PTSD patients lost their jobs, and/or were forced to 
retire. Lower incomes undoubtedly affected their social status as well as lifestyle and 
nutritional habits which resulted in lower nutritional quality, as shown by oil type 
consumption, although the higher BMI suggests that the quantity of food intake was not 
lowered. As reported by Braš et al.52, PTSD symptoms were associated with a lower quality 
of life in the affected population. Since it had not been possible to analyze the quality of 
nutrition at the moment of the disease onset no conclusions on this topic can be attempted, but 
bearing in mind the impact of certain nutrients like vitamins, selenium, iron and others on 
(anti)oxidative status, these relationships certainly deserve further attention. 
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Finally, some drawbacks of this study must be pointed out. The main one is the fact that the 
PTSD patients were on antidepressant therapy with sertraline, which might cause, through the 
alleviation of depressive symptoms, a reduction of plasma markers of oxidative stress.53 
However, the patients could have risked further exacerbation of clinical symptoms had this 
antidepressant been removed from their therapy. In order to avoid the dose effect, all the 
patients were on the same dose (50 mg/day). In addition, changes in the regulation of the HPA 
axis could be followed. Gotovac et al (2003)54 have shown in their longitudinal study on a 
similar group of PTSD patients initially increased cortisol levels and natural killer cell 
cytotoxicity (NKCC). However, cortisol levels decreased with the passing of time after a 
traumatic experience. It is worth noting that the changes in cortisol level reported in the 
above-mentioned study were still within the physiological range, as were the reported 
significantly lower activities of sSOD and sGPx, although still within reference values. 
Furthermore, only a few nutritional questions were included. Further, more detailed studies 
about the influence of nutritional and environmental factors on parameters of oxidative stress 
should bring new insights into mechanisms of the disease onset and development.  
In conclusion, the presence of increased oxidative stress indicators in patients suffering from 
PTSD could not be confirmed. However, our data suggest that lower catalytic concentrations 
of eSOD and eGPx in patients with PTSD may indicate a weakened response to oxidative 
stress due to impaired enzyme activity and/or decreased enzyme synthesis. Although no 
changes in MDA levels were found at the time of this study, presumably oxidative stress was 
present soon after the traumatic experience. Our results suggest a compensated balance 
between lipid peroxidation and enzymatic activity, though the lower level of oxidative stress 
due to therapy with antidepressants (sertraline) must also be taken into account.  Finally, 
oxidative stress might be involved in the onset of PTSD, but is not essentially responsible for 
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the continuance of the illness. Further studies are necessary to reveal the underlying 
mechanisms in PTSD development and possible treatments. 
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Table 1  
Socio-demographic characteristics of the study participants. 
 
 
Variables 
Control 
(n=30) 
PTSD 
(n=50) 
Statistics 
Age (years) (mean ± SD) 46.2 ± 6.3 47.1 ± 6.4 a t = - 0.643; P = 0.522 
Education level (%)   bχ2 = 28.982; P < 0.0001 
    ≤ 8 years of school 6.7 10.2  
    9 - 12 years of school 26.7 81.6  
    > 12 years of school 66.6 8.2  
Employment status (%)   bχ2 = 43.773; P < 0.0001 
    Full time 86.7 12.2  
    Unemployed 0 32.7  
    Retired 13.3 55.1  
Exposure time (%)    bχ2 = 2.275; P = 0.3206 
    1 to 6 months 13.8 6.1  
    7-12 months 17.2 20.4  
    1-2 years 17.2 28.6  
    More than 2 years 48.3 44.9  
Time since exposure (years) 15 ± 2 15 ± 2  
Oil consumption (%)   bχ2 = 8.864; P = 0.0119 
    Sunflower 46 69*  
    Olive 28 4*  
    Others 26 27  
Fish consumption (%)   bχ2 = 1.043; P = 0.5936 
    Rarely 36.7 40.8  
    Regularly 60.0 51.0  
    Often 3.3 8.2  
BMI (kg/m2) (mean ± SD) 27.0 ± 4.7 27.3 ± 3.9 at = -0.001; P = 0.999 
TCH (mmol/L) (mean ± SD) 5.67 ± 1.23 5.45 ± 1.14 at = 0.787; P = 0.6559 
LDL-CH (mmol/L) (mean ± SD) 3.37 ± 0.77 3.42 ± 0.87 at = -0.218; P = 0.5117 
HDL-CH (mmol/L) (mean ± SD) 1.26 ± 0.27 1.24 ± 0.32 at = 0.249; P = 0.3233 
TG (mmol/L) (mean ± SD) 1.95 ± 0.89 1.87 ± 1.09 at = 0.349; P = 0.2471 
 
BMI = body mass index; TCH = total cholesterol; LDL-CH = low density lipoprotein 
cholesterol; HDL-CH = high density lipoprotein cholesterol; TG = triglycerides;  
aStudent-t test, bChi-square test. 
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Table 2 
Erythrocyte superoxide dismutase (eSOD) and glutathione peroxidase (eGPx) catalytic 
concentrations and serum lipid peroxide (sMDA) concentration in patients with PTSD and 
controls included in the study. 
 
 
Variable Control PTSD Statistics 
eSOD (U/g Hb) 
(mean±SD) 
1180.6±271.2 966.2±192.0 ta = 4.1307; p = 0.000090 
eGPx (U/g Hb) 
(mean±SD) 
67.5±27.3 48.6±20.1 ta = 3.53797; p = 0.000683 
sMDA (µmol/L) 
(mean±SD) 
0.40±0.34 0.22±0.11 ta = 1.373; p = 0.174 
 
Values are expressed as mean ± SD. a Student-t test 
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Fig. 1. Comparison between the scores in PTSD patients obtained by Beck Depression 
Inventory (BDI-II), Hospital Anxiety and Depression Scale for anxiety (HADS-A) and 
depression (HADS-D), and Clinical Global Impression-Severity scale (CGI-S). Values are 
expressed as percentage of total group. 
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Fig. 2. Erythrocyte superoxide dismutase (eSOD) and glutathione peroxidase (eGPx) catalytic 
concentrations and serum lipid peroxide (sMDA) concentration in patients with PTSD and 
controls included in the study. Values are expressed as mean ± SD. *P < 0.05 
 
 
 
 
 
